European Archives - Page 651 of 1003 - European Medical Journal

Facial Lesions: A Dermoscopic Interactive Session

The differential diagnosis of pigmented macules on sun-damaged facial skin is one of the most challenging procedures in daily dermatological practice.

PASI 90/100, DLQI 0/1, and IL-17 Receptor/Cytokine: Does it Make a Difference and Are We Ambitious Enough?

The main objectives of the symposium were to review recent evidence on what difference targeting Psoriasis Area Severity Index (PASI) 90 or 100 and…

The Influence of Itch and Pain on Sleep in Atopic Dermatitis Patients

Atopic dermatitis (AD) is a common chronic inflammatory skin disease, with the average prevalence ranging from 2.1–4.9% in the general population.

Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey

The importance of discussions around the management of women of childbearing age with psoriasis, an issue that has been largely neglected for many years…

A Case of Bazex Syndrome (Acrokeratosis Paraneoplastica) with Atypical Features

Acrokeratosis paraneoplastica (Bazex syndrome) is a paraneoplastic skin condition that can be found in the context of various internal malignancies…

Is Complete Skin Clearance in Psoriasis the Answer?

Prof Reich outlined the new understanding of psoriasis pathogenesis, with IL-23 rather than IL-12 considered the pivotal cytokine pathway. This…

IL-23 Inhibition in Psoriasis: Changing the Present, Shaping the Future

This symposium took place at the 27th European Academy of Dermatology and Venereology (EADV) Congress. The session examined the latest data for…

Polymorphic Eruption of Pregnancy with Postpartum Onset: A Case Report

Polymorphic eruption of pregnancy (PEP), also known as pruritic urticarial papules and plaques of pregnancy, is a self-limiting inflammatory dermatosis…

Clinical and Psychological Aspects in Patients with Alopecia Areata Treated with Diphenylcyclopropenone

Alopecia areata (AA) is a condition that causes non-scarring hair loss; the estimated lifetime risk of developing the disorder is 1.7% but the aetiology…

From Evolution to Revolution: IL-23 in the Treatment of Psoriasis Patients

This symposium, which took place during the 2018 meeting of the European Academy of Dermatology and Venereology (EADV) in Paris, France, provided…